MicroRNA-143 is Associated With Pathological Complete Response and Regulates Multiple Signaling Proteins in Breast Cancer

Almost 55% to 80% of patients with breast cancer have an unfavorable pathological complete response to chemotherapy. MicroRNAs are small noncoding RNAs involved in cancer progression; however, their utility as predictors of pathological complete response to neoadjuvant chemotherapy is unclear. Here,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Technol Cancer Res Treat
Главные авторы: García-Vázquez, Raúl, Marchat, Laurence A., Ruíz-García, Erika, Astudillo-de la Vega, Horacio, Meneses-García, Abelardo, Arce-Salinas, Claudia, Bargallo-Rocha, Enrique, Carlos-Reyes, Ángeles, López-González, José Sullivan, Pérez-Plasencia, Carlos, Ramos-Payán, Rosalío, Aguilar-Medina, Maribel, López-Camarillo, César
Формат: Artigo
Язык:Inglês
Опубликовано: SAGE Publications 2019
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6378643/
https://ncbi.nlm.nih.gov/pubmed/30755102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1533033819827309
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы